Department of Hepatobiliary Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou City, China.
Academician (Expert) Workstation of Sichuan Province, Luzhou City, China.
J Invest Surg. 2021 Nov;34(11):1214-1222. doi: 10.1080/08941939.2020.1792009. Epub 2020 Jul 13.
Here, we aimed to compare early hepatectomy (EH) with delayed hepatectomy (DH) as a treatment for spontaneously ruptured hepatocellular carcinoma (HCC).
Several databases were systematically searched for eligible studies that compared DH with EH for spontaneously ruptured HCC treatment. Studies that met the inclusion criteria were reviewed systematically, and the reported data were aggregated statistically, using the RevMan v5.3 software.
Seven studies were included, with a total of 385 patients, comprising of 224 EH cases and 161 DH cases. Compared with the EH group, incidence of intraoperative bleeding [mean difference (MD), 353.93; 95% CI, 230.04-447.83; < 0.00001], volume of intraoperative blood transfusion (MD, 420.61; 95% CI, 354.40-486.81, < 0.00001), and 30-day mortality rate (OR, 14.94; 95% CI, 1.76-126.66; = 0.01) were significantly lower in the DH group. Furthermore, the 1-, 2-, and 3-year survival rates were significantly higher in the DH group [1-year:hazard ratio (HR), 1.76; 95% CI, 1.06-2.94; = 0.03; 2-year:HR, 1.52; 95% CI, 1.02-2.25; = 0.04; 3-year: HR, 1.53; 95% CI, 1.06-2.21; = 0.02]. There was no difference between the groups in the 5-year survival rate (HR, 1.40; 95% CI, 0.92-2.11; = 0.11).
For resectable spontaneously ruptured HCC, DH could reduce intraoperative bleeding, intraoperative blood transfusion volume, and 30-day mortality rate and increase the 1-, 2-, and 3-year survival rates, endowing the patients with greater short- and long-term benefits during and following the surgery.
本研究旨在比较自发性肝癌破裂后早期肝切除术(EH)与延迟肝切除术(DH)的治疗效果。
系统检索了比较 DH 与 EH 治疗自发性肝癌破裂的相关研究,纳入符合标准的研究进行系统评价,并采用 RevMan v5.3 软件对报告数据进行统计学汇总。
共纳入 7 项研究,总计 385 例患者,其中 224 例接受 EH,161 例接受 DH。与 EH 组相比,DH 组术中出血量[均数差(MD),353.93;95%置信区间(CI),230.04-447.83; < 0.00001]、术中输血量(MD,420.61;95% CI,354.40-486.81; < 0.00001)和 30 天死亡率(OR,14.94;95% CI,1.76-126.66; = 0.01)均显著降低,且 DH 组 1、2、3 年生存率显著更高[1 年:风险比(HR),1.76;95% CI,1.06-2.94; = 0.03;2 年:HR,1.52;95% CI,1.02-2.25; = 0.04;3 年:HR,1.53;95% CI,1.06-2.21; = 0.02]。两组间 5 年生存率差异无统计学意义(HR,1.40;95% CI,0.92-2.11; = 0.11)。
对于可切除的自发性肝癌破裂患者,DH 可减少术中出血量、输血量,降低 30 天死亡率,提高 1、2、3 年生存率,为患者带来更多的短期和长期获益。